IMAC Holdings, Inc. (BACK)
NASDAQ: BACK · Real-Time Price · USD
0.982
0.00 (0.01%)
Nov 21, 2024, 1:59 PM EST - Market open
IMAC Holdings Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
1.69M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| cbdMD | 20.64M |
| iCoreConnect | 11.05M |
| Akanda | 2.51M |
| 60 Degrees Pharmaceuticals | 462.61K |
| Sonnet BioTherapeutics Holdings | 55.88K |
| Aclarion | 49.29K |
BACK News
- 7 days ago - IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1) - GlobeNewsWire
- 2 months ago - IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology - GlobeNewsWire
- 3 months ago - IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q - GlobeNewsWire
- 4 months ago - IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors - GlobeNewsWire
- 6 months ago - IMAC Holdings Announces Leadership Succession - GlobeNewsWire
- 7 months ago - IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business - GlobeNewsWire
- 1 year ago - IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 1 year ago - IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split - GlobeNewsWire